41
Participants
Start Date
June 30, 2002
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
OSI-774
OSI-774 is an orally active, potent, selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase.
University of Texas Health Science Center San Antonio, San Antonio
National Cancer Institute (NCI)
NIH
The University of Texas Health Science Center at San Antonio
OTHER